Each central nervous system–active medication prescribed at hospital discharge was associated with incrementally higher 12-month readmission rate and mortality.
In a high-risk, difficult-to-treat population, this targeted therapy was superior to another evidence-based psychotherapy, reinforcing that CBT is the suicide-prevention therapy of choice.